Literature DB >> 19251725

Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors.

Thomas H Schindler1, Roxana Campisi, Deborah Dorsey, John O Prior, Manfred Olschewski, James Sayre, Heinrich R Schelbert.   

Abstract

AIMS: The aim of this study was to evaluate the effect of hormone replacement therapy (HRT) on coronary vasomotor function in post-menopausal women (PM) with medically treated cardiovascular risk factors (RFs) in a cross-sectional and a longitudinal follow-up (FU) study. METHODS AND
RESULTS: Myocardial blood flow (MBF) response to cold pressor testing (CPT) and during pharmacologically induced hyperaemia was measured with positron emission tomography in pre-menopausal women (CON), in PM with HRT and without HRT, and repeated in PM after a mean FU of 24 +/- 14 months. When compared with CON at baseline, the endothelium-related change in MBF (DeltaMBF) to CPT progressively declined in PM with HRT and without HRT (0.35 +/- 0.23 vs. 0.24 +/- 0.20 and 0.16 +/- 0.12 mL/g/min; P = 0.171 and P = 0.021). In PM without HRT and in those with HRT at baseline but with discontinuation of HRT during FU, the endothelium-related DeltaMBF to CPT was significantly less at FU than at baseline (0.05 +/- 0.19 vs. 0.16 +/- 0.12 and -0.03 +/- 0.14 vs. 0.25 +/- 0.18 mL/g/min; P = 0.023 and P = 0.001), whereas no significant change was observed in PM with HRT (0.19 +/- 0.22 vs. 0.23 +/- 0.22 mL/g/min; P = 0.453). Impaired hyperaemic MBFs when compared with CON were not significantly altered from those at baseline exam.
CONCLUSION: Long-term administration of oestrogen may contribute to maintain endothelium-dependent coronary function in PM with medically treated cardiovascular RFs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251725      PMCID: PMC2721713          DOI: 10.1093/eurheartj/ehp013

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

1.  Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women.

Authors:  L R Peterson; D Eyster; V G Dávila-Román; A L Stephens; K B Schechtman; P Herrero; R J Gropler
Journal:  Am Heart J       Date:  2001-10       Impact factor: 4.749

Review 2.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

3.  Hormone therapy and risk of myocardial infarction: a national register study.

Authors:  Ellen Løkkegaard; Anne Helms Andreasen; Rikke Kart Jacobsen; Lars Hougaard Nielsen; Carsten Agger; Øjvind Lidegaard
Journal:  Eur Heart J       Date:  2008-09-30       Impact factor: 29.983

4.  Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration.

Authors:  Roxana Campisi; Lauren Nathan; Miguel Hernandez Pampaloni; Heiko Schöder; James W Sayre; Gautam Chaudhuri; Heinrich R Schelbert
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

5.  Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

Authors:  U Laufs; M Endres; F Custodis; K Gertz; G Nickenig; J K Liao; M Böhm
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

6.  Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.

Authors:  C S Duvernoy; J Rattenhuber; V Seifert-Klauss; F Bengel; C Meyer; M Schwaiger
Journal:  J Gend Specif Med       Date:  2001

7.  Time since menopause influences the acute and chronic effect of estrogens on endothelial function.

Authors:  Cristiana Vitale; Giuseppe Mercuro; Elena Cerquetani; Giuseppe Marazzi; Roberto Patrizi; Francesco Pelliccia; Maurizio Volterrani; Massimo Fini; Peter Collins; Giuseppe M C Rosano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-06       Impact factor: 8.311

8.  Myocardial blood flow and flow reserve in response to hormone therapy in postmenopausal women with risk factors for coronary disease.

Authors:  C Duvernoy; J Martin; K Briesmiester; A Bargardi; O Muzik; L Mosca
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET.

Authors:  Thomas H Schindler; Xiao-Li Zhang; John O Prior; Jerson Cadenas; Magnus Dahlbom; James Sayre; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-03       Impact factor: 10.057

Review 10.  Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis.

Authors:  Gillian M Sare; Laura J Gray; Philip M W Bath
Journal:  Eur Heart J       Date:  2008-07-03       Impact factor: 29.983

View more
  10 in total

1.  Myocardial blood flow: Putting it into clinical perspective.

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

2.  Vascular function of the peripheral and coronary circulation: worthwhile to assess their relation?

Authors:  Ines Valenta; Ulf Landmesser; Thomas H Schindler
Journal:  J Nucl Cardiol       Date:  2011-04       Impact factor: 5.952

Review 3.  Coronary microvascular dysfunction in women with nonobstructive ischemic heart disease as assessed by positron emission tomography.

Authors:  Roxana Campisi; Fernando D Marengo
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 4.  Longitudinal myocardial blood flow gradient and CAD detection.

Authors:  Ines Valenta; Richard L Wahl; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

5.  Thoracic fat volume is independently associated with coronary vasomotion.

Authors:  Vincent Dunet; François Feihl; Amin Dabiri; Gilles Allenbach; Bernard Waeber; Raphaël Heinzer; John O Prior
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-19       Impact factor: 9.236

6.  Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus.

Authors:  Thomas H Schindler; Jerson Cadenas; Alvaro D Facta; Yanjie Li; Manfred Olschewski; James Sayre; Jonathan Goldin; Heinrich R Schelbert
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983

Review 7.  Positron Emission Tomography-Determined Hyperemic Flow, Myocardial Flow Reserve, and Flow Gradient-Quo Vadis?

Authors:  Thorsten M Leucker; Ines Valenta; Thomas Hellmut Schindler
Journal:  Front Cardiovasc Med       Date:  2017-07-17

8.  EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging.

Authors:  Roberto Sciagrà; Mark Lubberink; Fabien Hyafil; Antti Saraste; Riemer H J A Slart; Denis Agostini; Carmela Nappi; Panagiotis Georgoulias; Jan Bucerius; Christoph Rischpler; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-02       Impact factor: 9.236

9.  Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals.

Authors:  Alessandra Quercioli; Fabrizio Montecucco; Katia Galan; Osman Ratib; Pascale Roux-Lombard; Sabrina Pagano; François Mach; Thomas H Schindler; Nicolas Vuilleumier
Journal:  Mediators Inflamm       Date:  2012-11-07       Impact factor: 4.711

Review 10.  Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.

Authors:  Eglė Kazakauskaitė; Diana Žaliaduonytė-Pekšienė; Eglė Rumbinaitė; Justas Keršulis; Ilona Kulakienė; Renaldas Jurkevičius
Journal:  Medicina (Kaunas)       Date:  2018-07-11       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.